Article citationsMore>>

Maccora, I., Dell’Anna, M.P., Vannacci, A. and Simonini, G. (2020) Safety Evaluations of Adalimumab for Childhood Chronic Rheumatic Diseases. Expert Opinion on Drug Safety, 19, 661-671.
https://doi.org/10.1080/14740338.2020.1763300

has been cited by the following article:

• TITLE: Progress in the Use of Glucocorticoids and Biological Agents in Non-Infectious Uveitis

  AUTHORS: Yuxuan Liu, Xunyu Zou, Shizhou Cheng, Zuhai Zhang

  KEYWORDS: Non-Infectious Uveitis, Glucocorticoids, Biological Agents

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.2, February 7, 2024

  ABSTRACT: One of the main immune-mediated diseases that lead to avoidable blindness is non-infectious uveitis. Glucocorticoids are the first-line therapy choice for noninfectious uveitis; however, biologics are also showing promise in the management of this condition. The description of glucocorticoid and biologic usage in non-infectious uveitis is the main topic of this paper.